Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiming Fan

Showing results (61-70 of 669) with videos related to

Pageof 67
Sort By:
Current Drug Targets|July 10, 2013
Function of miRNA in controlling drug resistance of human cancersLiu Hong, Zhiping Yang, Jiaojiao Ma, et al.
Gastroenterology Research and Practice|September 23, 2014
Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysisXingshun Qi, Ming Bai, Xiaozhong Guo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 29, 2012
Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension?Xingshun Qi, Ming Bai, Guohong Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Brivanib for hepatocellular carcinoma trials: selection bias from barcelona clinic liver cancer stage?Xingshun Qi, Jia Jia, Daiming Fan, et al.
The American Journal of Medicine|August 31, 2010
Anticoagulation for portal vein thrombosis in cirrhosisXingshun Qi, Guohong Han, Kaichun Wu, et al.
Oncotarget|October 6, 2017
Colorectal adenoma recurrence rates among post-polypectomy patients in the placebo-controlled groups of randomized clinical trials: a meta-analysisXin Shi, Zhiping Yang, Qiong Wu, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2007
Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006)Shirong Li, Jiheng Wang, Yuanyuan Lu, et al.
Hepatology (Baltimore, Md.)|July 28, 2011
I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese populationXiaohua Li, Qingchuan Zhao, Kaichun Wu, et al.
Annals of Gastroenterology|April 10, 2014
Cholangitis in a patient with hepatic hydatidosisXingshun Qi, Guohong Han, Wengang Guo, et al.
European Journal of Gastroenterology & Hepatology|April 4, 2014
Prevalence of thrombotic risk factors in Chinese Budd-Chiari syndrome patients: results of a prospective validation studyXingshun Qi, Feifei Wu, Daiming Fan, et al.
Pageof 67

Showing results (61-70 of 669) with videos related to

Sort By:
Pageof 67
Current Drug Targets|July 10, 2013
Function of miRNA in controlling drug resistance of human cancersLiu Hong, Zhiping Yang, Jiaojiao Ma, et al.
Gastroenterology Research and Practice|September 23, 2014
Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysisXingshun Qi, Ming Bai, Xiaozhong Guo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 29, 2012
Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension?Xingshun Qi, Ming Bai, Guohong Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Brivanib for hepatocellular carcinoma trials: selection bias from barcelona clinic liver cancer stage?Xingshun Qi, Jia Jia, Daiming Fan, et al.
The American Journal of Medicine|August 31, 2010
Anticoagulation for portal vein thrombosis in cirrhosisXingshun Qi, Guohong Han, Kaichun Wu, et al.
Oncotarget|October 6, 2017
Colorectal adenoma recurrence rates among post-polypectomy patients in the placebo-controlled groups of randomized clinical trials: a meta-analysisXin Shi, Zhiping Yang, Qiong Wu, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2007
Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006)Shirong Li, Jiheng Wang, Yuanyuan Lu, et al.
Hepatology (Baltimore, Md.)|July 28, 2011
I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese populationXiaohua Li, Qingchuan Zhao, Kaichun Wu, et al.
Annals of Gastroenterology|April 10, 2014
Cholangitis in a patient with hepatic hydatidosisXingshun Qi, Guohong Han, Wengang Guo, et al.
European Journal of Gastroenterology & Hepatology|April 4, 2014
Prevalence of thrombotic risk factors in Chinese Budd-Chiari syndrome patients: results of a prospective validation studyXingshun Qi, Feifei Wu, Daiming Fan, et al.
Pageof 67